Omega Healthcare CLO exercises 40,964 performance units

Omega Healthcare Investors chief legal officer Gail D. Makode reported compensation-related equity activity.

Rhea-AI Filing Summary

Omega Healthcare Investors chief legal officer Gail D. Makode reported compensation-related equity activity. On June 30, 2026, she exercised derivative awards covering a total of 40,964 units, including Profits Interest Units and OP Units, at an exercise price of $0.00 per unit.

Footnotes explain that each Profits Interest Unit can vest into one OP Unit of the operating partnership, and each OP Unit is redeemable for cash equal to the fair market value of one share of Omega common stock, or, at the company’s election, one share of common stock. The vested portions reflect 25% tranches tied to absolute and relative total shareholder return performance for the 2023–2025 period, with vesting spread across calendar quarters in 2026 and subject to continued employment. The filing shows no open‑market sales or gifts.

Insider Trade Summary

40,964 shares exercised/converted

Exercise 4 txns

Insider Makode Gail D

Role CHIEF LEGAL OFFICER

Type	Security	Shares	Price	Value
Exercise	Profits Interest Units	14,862	$0.00	$0.00
Exercise	Profits Interest Units	5,620	$0.00	$0.00
Exercise	OP Units	14,862	$0.00	$0.00
Exercise	OP Units	5,620	$0.00	$0.00

Holdings After Transaction: Profits Interest Units — 80,719 contracts (Direct); OP Units — 244,990 contracts (Direct)

Footnotes (4)

1. F1. Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements.
2. F2. Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. The OP Units have no expiration date.
3. F3. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2026 based on the Absolute Total Shareholder Return for the 2023-2025 performance period, subject to continued employment and accelerated vesting under certain circumstances, as certified by the Compensation Committee on January 8, 2026.
4. F4. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2026 based on the Relative Total Shareholder Return for the 2023-2025 performance period, subject to continued employment and accelerated vesting under certain circumstances, as certified by the Compensation Committee on January 8, 2026.

Key Figures

Total derivative exercises: 40,964 units First OP Unit exercise: 5,620 OP Units Second OP Unit exercise: 14,862 OP Units +5 more

8 metrics

Total derivative exercises 40,964 units Aggregate exerciseShares across four M-code transactions

First OP Unit exercise 5,620 OP Units OP Units exercised on June 30, 2026

Second OP Unit exercise 14,862 OP Units OP Units exercised on June 30, 2026

First PIU conversion 5,620 PIUs Profits Interest Units vesting into OP Units

Second PIU conversion 14,862 PIUs Profits Interest Units vesting into OP Units

OP Units holding example 244,990 OP Units Total OP Units following one exercise transaction

PIUs holding example 86,339 PIUs Profits Interest Units following one conversion transaction

Exercise price $0.00 per unit Conversion or exercise price for reported derivative transactions

Key Terms

Profits Interest Units, OP Units, Absolute Total Shareholder Return, Relative Total Shareholder Return, +1 more

5 terms

Profits Interest Units financial

"Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership"

OP Units financial

"Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit")"

OP units are ownership stakes in an operating partnership that sits beneath a public parent company, commonly used by real estate and energy firms to hold assets and distributions. Think of them like special shares in a subsidiary: they give economic rights to profits and cash payouts but are structured differently from the parent’s common stock, so investors watch OP unit issuance because it can change the effective ownership, future distributions, and potential dilution of the parent company’s equity.

Absolute Total Shareholder Return financial

"based on the Absolute Total Shareholder Return for the 2023-2025 performance period"

Relative Total Shareholder Return financial

"based on the Relative Total Shareholder Return for the 2023-2025 performance period"

Relative total shareholder return measures how much an investor’s gain from a company — including stock price changes and dividends — beats or lags a chosen benchmark or peer group over a set time. Think of it as a race: it shows whether the company outpaced rivals or the market, which helps investors and boards judge performance, compare returns fairly, and link results to pay or investment decisions.

limited partnership interest financial

"one unit of limited partnership interest (an "OP Unit") in the Operating Partnership"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Omega Healthcare (OHI) report for Gail D. Makode?

Gail D. Makode exercised derivative awards for 40,964 units. The Form 4 shows four "M" code transactions converting Profits Interest Units and OP Units at a $0.00 exercise price, with no open-market purchases, sales, gifts, or tax-withholding dispositions reported.

What are Profits Interest Units in Omega Healthcare (OHI) according to this Form 4?

Profits Interest Units represent contingent rights to OP Units. Each PIU in OHI Healthcare Properties Limited Partnership can vest into one OP Unit upon meeting vesting and tax-related conditions, giving the holder potential economic exposure similar to limited partnership interests linked to Omega common stock.

How are OP Units related to Omega Healthcare (OHI) common stock in this filing?

Each OP Unit is redeemable based on Omega common stock value. The holder may elect redemption for cash equal to the fair market value of one share of Omega common stock, or, at the company’s election, receive one share of Omega common stock instead.

What performance metrics drove the vesting of units for Omega Healthcare (OHI) in this Form 4?

Vesting was based on total shareholder return metrics for 2023–2025. Footnotes describe Absolute Total Shareholder Return and Relative Total Shareholder Return over the 2023–2025 performance period, with the Compensation Committee certifying results on January 8, 2026.

How did the vesting schedule work for Omega Healthcare (OHI) Profits Interest Units in 2026?

Twenty‑five percent of certain PIUs vested each calendar quarter in 2026. The vesting depended on the 2023–2025 total shareholder return outcomes, continued employment, and possible accelerated vesting under specified circumstances, as certified by the Compensation Committee.

Did the Omega Healthcare (OHI) insider transaction include any sales of common stock?

No sales of common stock were reported in this Form 4. All transactions were coded "M" for exercises or conversions of derivative securities, with no "P" or "S" codes indicating open‑market purchases or sales and no tax-withholding or gift entries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Makode Gail D

(Last) (First) (Middle)

303 INTERNATIONAL CIRCLE

SUITE 200

(Street)

HUNT VALLEY MARYLAND 21030

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF LEGAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Profits Interest Units	(1)(2)	06/30/2026		M			14,862	(3)	(3)	OP Units	14,862	$0	86,339	D
Profits Interest Units	(1)(2)	06/30/2026		M			5,620	(4)	(4)	OP Units	5,620	$0	80,719	D
OP Units	(2)	06/30/2026		M		14,862		(2)	(2)	Common Stock	14,862	$0	239,370	D
OP Units	(2)	06/30/2026		M		5,620		(2)	(2)	Common Stock	5,620	$0	244,990	D

Explanation of Responses:

1. Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements.

2. Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. The OP Units have no expiration date.

3. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2026 based on the Absolute Total Shareholder Return for the 2023-2025 performance period, subject to continued employment and accelerated vesting under certain circumstances, as certified by the Compensation Committee on January 8, 2026.

4. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2026 based on the Relative Total Shareholder Return for the 2023-2025 performance period, subject to continued employment and accelerated vesting under certain circumstances, as certified by the Compensation Committee on January 8, 2026.

	/s/ Meghan C. Lyons, Attorney-in-Fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)